Daily Bulletin

Men's Weekly

.

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision
  • Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety Disorder
  • Phase 2 clinical trial on target to start by end of 2021 and expected to read out topline data by end of 2022

ADELAIDE, Australia, Sept. 20, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO,...

Read more: Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

Business News

What Designers Really Think About Your Current Marketing Collateral

Key Takeaways: Designers notice structure, typography, and colour choices before the content itself Consistency across all collateral strengthens brand recognition and builds trust Overly bu...

Daily Bulletin - avatar Daily Bulletin

How to Choose the Right Air Conditioner for Your Home or Business

In Australia’s climate, where summer heat can be intense and winter chills are felt in many regions, air conditioning has become more than just a luxury; it’s an essential part of comfortable living. ...

Daily Bulletin - avatar Daily Bulletin

Why Heavy Duty Moving Dollies Are Essential for Safe Transport in Australia

Moving heavy or bulky items can be challenging, especially when it involves transporting goods across warehouses, offices, or even during residential relocations. In Australia, where industries like c...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals